Christopher P. Gilfillan

Level 2, 5 Arnold Street, 
Box Hill, VIC, AU 
Level 2, 5 Arnold Street, 
Box Hill, VIC, AU 

Overview

Christopher Gilfillan practices practicing medicine in Box Hill, Australia.

His clinical expertise encompasses Superior Mesenteric Artery Syndrome (SMAS), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Gestational Diabetes.

He is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Level 2, 5 Arnold Street, Box Hill, VIC 3128, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3

27 Total Publications

An equity audit on intervention effects of a cardiometabolic risk reduction program for women with a history of gestational diabetes in Victoria, Australia.
An equity audit on intervention effects of a cardiometabolic risk reduction program for women with a history of gestational diabetes in Victoria, Australia.
Journal: Preventive medicine
Published: July 14, 2025

Frequently Asked Questions about Christopher P. Gilfillan

Is Christopher P. Gilfillan a top-rated expert for Superior Mesenteric Artery Syndrome (SMAS)?

MediFind is an objective health platform that identifies experts based on real-world data. Christopher P. Gilfillan is classified as an Experienced expert for Superior Mesenteric Artery Syndrome (SMAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christopher P. Gilfillan participate in research or clinical trials?

Yes. Christopher P. Gilfillan has published 27 articles and abstracts on conditions like Superior Mesenteric Artery Syndrome (SMAS). You can view a list of Christopher P. Gilfillan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gilfillan's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile